APOLLO HOSPITALS ENTER. L vs Gennex Laboratories Ltd

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and Gennex Laboratories Ltd (GENNEXLABORATORIESLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs GENNEXLABORATORIESLTD on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

64.15
P/E ratio
15.30
12.55
P/B ratio
1.41
0.23%
Dividend yield
0.00%
₹135.04
EPS
₹0.76

Profitability

APOLLOHOSP takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
9.25%
18.00%
Return on capital
11.00%
15.00%
EBITDA margin
13.00%
7.94%
Net margin
12.14%

Growth

GENNEXLABORATORIESLTD takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
37.88%
33.39%
Profit CAGR (3Y)
61.34%

Size & financial health

APOLLOHOSP takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.25L Cr
Market cap
₹309 Cr
₹25,228 Cr
Revenue
₹173 Cr
₹2,003 Cr
Net profit
₹21 Cr
0.32
Debt / equity
0.36
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Gennex Laboratories Ltd
  • + ["Company has delivered good profit growth of 34.4% CAGR over last 5 years"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Promoter holding is low: 23.6%", "Tax rate seems low", "Company has a low return on equity of 9.82% over last 3 years.", "Debtor days have increased from 68.2 to 92.0 days."]
APOLLO HOSPITALS ENTER. L full analysis Gennex Laboratories Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLOHOSP vs GENNEXLABORATORIESLTD: Share Price, Valuation & Which to Buy | DocStoX